Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Scherer

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Cancer Discovery|March 20, 2023
Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma PrecursorsJoseph G Schroers-Martin, Joanne Soo, Gabriel Brisou, et al.
Neuro-Oncology|September 15, 2023
Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomasEliza M Lauer, Ella Riegler, Jurik A Mutter, et al.
Neuro-Oncology|April 10, 2024
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO reviewLakshmi Nayak, Chetan Bettegowda, Florian Scherer, et al.
Cell|July 9, 2019
Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome PredictionDavid M Kurtz, Mohammad S Esfahani, Florian Scherer, et al.
Nature Biotechnology|March 29, 2016
Integrated digital error suppression for improved detection of circulating tumor DNAAaron M Newman, Alexander F Lovejoy, Daniel M Klass, et al.
Molecular Oncology|October 15, 2021
Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancerSilvia Waldeck, Jan Mitschke, Sebastian Wiesemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2021
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell LymphomaStefan Alig, Charles W Macaulay, David M Kurtz, et al.
BMC Cancer|August 18, 2023
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trialLisa K Isbell, Roswitha Uibeleisen, Alexander Friedl, et al.
Nature Communications|June 11, 2016
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patientsJacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, et al.
Nature Communications|February 18, 2022
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10Vidhya M Ravi, Nicolas Neidert, Paulina Will, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Cancer Discovery|March 20, 2023
Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma PrecursorsJoseph G Schroers-Martin, Joanne Soo, Gabriel Brisou, et al.
Neuro-Oncology|September 15, 2023
Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomasEliza M Lauer, Ella Riegler, Jurik A Mutter, et al.
Neuro-Oncology|April 10, 2024
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO reviewLakshmi Nayak, Chetan Bettegowda, Florian Scherer, et al.
Cell|July 9, 2019
Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome PredictionDavid M Kurtz, Mohammad S Esfahani, Florian Scherer, et al.
Nature Biotechnology|March 29, 2016
Integrated digital error suppression for improved detection of circulating tumor DNAAaron M Newman, Alexander F Lovejoy, Daniel M Klass, et al.
Molecular Oncology|October 15, 2021
Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancerSilvia Waldeck, Jan Mitschke, Sebastian Wiesemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2021
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell LymphomaStefan Alig, Charles W Macaulay, David M Kurtz, et al.
BMC Cancer|August 18, 2023
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trialLisa K Isbell, Roswitha Uibeleisen, Alexander Friedl, et al.
Nature Communications|June 11, 2016
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patientsJacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, et al.
Nature Communications|February 18, 2022
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10Vidhya M Ravi, Nicolas Neidert, Paulina Will, et al.
Pageof 6